Frank Musshoff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Frank Musshoff has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
Burkhard Madea
Institute of Forensic Medicine, Rheinische Friedrich-Wilhems-University, Bonn, Germany
30 shared publicationsB. Madea
University Hospital, Institute of Forensic Medicine Stiftsplatz 12 53111 Bonn Germany
22 shared publicationsB Madea
15 shared publications- Dirk Walter Lachenmeier
Chemisches und Veterinäruntersuchungsamt Karlsruhe, Karlsruhe, Germany, Germany
10 shared publications P Schmidt
Institute of Legal Medicine, Bonn, Germany
9 shared publicationsR Dettmeyer
5 shared publications
Latest Publications
- 1 May 2014
- Published by Elsevier in Forensic Science International
- Vol. 238, 120-124
Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany
- 1 May 2014
- Published by Elsevier in Forensic Science International
- Vol. 238, 120-124
Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany
- 1 October 2013
- Published by Elsevier in Forensic Science International
- Vol. 232 (1-3) , 213-217
Ethyl glucuronide findings in hair samples from the mummies of the Capuchin Catacombs of Palermo
- 1 October 2013
- Published by Elsevier in Forensic Science International
- Vol. 232 (1-3) , 213-217
Ethyl glucuronide findings in hair samples from the mummies of the Capuchin Catacombs of Palermo
- 15 May 2013
- Published by Wiley in Drug Testing and Analysis
- Vol. 5 (9-10) , 741-744
Nurse induced respiratory depression by succinylcholine – the ‘hero syndrome’
A nurse administered the neuromuscular blocking agent succinylcholine (SUX) to at least one patient and gave first aid in the therapy of unexpected respiratory depression. SUX is regarded as an undetectable and thus perfect poison due to its short half‐life and degradation to the endogenous compounds choline and succinic acid. However, SUX and especially its metabolite succinylmonocholine (SMC) were found in plasma and urine a few hours after administration by means of high performance liquid chromatography‐tandem mass spectrometry (HPLC‐MS/MS). Compared to clinical studies, the window of detection was sufficient to gain definite proof; in other cases no samples were collected. The nurse enjoyed high reputation with the doctors. According to the court she wanted to present herself spectacularly as the first and decisive rescuer to demonstrate her special abilities and capacities, perhaps to receive a better job in the hospital. Considering the actual case, the hero syndrome is not limited to fire‐fighters. Copyright © 2013 John Wiley & Sons, Ltd.
- 15 May 2013
- Published by Wiley in Drug Testing and Analysis
- Vol. 5 (9-10) , 741-744
Nurse induced respiratory depression by succinylcholine – the ‘hero syndrome’
A nurse administered the neuromuscular blocking agent succinylcholine (SUX) to at least one patient and gave first aid in the therapy of unexpected respiratory depression. SUX is regarded as an undetectable and thus perfect poison due to its short half‐life and degradation to the endogenous compounds choline and succinic acid. However, SUX and especially its metabolite succinylmonocholine (SMC) were found in plasma and urine a few hours after administration by means of high performance liquid chromatography‐tandem mass spectrometry (HPLC‐MS/MS). Compared to clinical studies, the window of detection was sufficient to gain definite proof; in other cases no samples were collected. The nurse enjoyed high reputation with the doctors. According to the court she wanted to present herself spectacularly as the first and decisive rescuer to demonstrate her special abilities and capacities, perhaps to receive a better job in the hospital. Considering the actual case, the hero syndrome is not limited to fire‐fighters. Copyright © 2013 John Wiley & Sons, Ltd.
- 1 May 2013
- Published by Springer Nature in International journal of legal medicine
- Vol. 128 (1) , 59-64
Driving under the influence of synthetic cannabinoids (“Spice”): a case series
Recreational use of synthetic cannabinoid receptor agonists—so-called “Spice” products—became very popular during the last few years. Several reports on clinical symptoms and poisonings were published. Unfortunately, most of these reports do not contain any analytical data on synthetic cannabinoids in body fluids, and no or only a limited number of cases were reported concerning driving under the influence (DUI) of this kind of drugs. In this article, several cases of DUI of synthetic cannabinoids (AM-2201, JWH-018, JWH-019, JWH-122, JWH-210, JWH-307, MAM-2201 (JWH-122 5-fluoropentyl derivative), and UR-144) are presented, focusing on analytical results and signs of impairment documented by the police or the physicians who had taken the blood sample from the suspects. Consumption of synthetic cannabinoids can lead to impairment similar to typical performance deficits caused by cannabis use which are not compatible with safe driving. These deficits include centrally sedating effects and impairment of fine motor skills necessary for keeping the vehicle on track. Police as well as forensic toxicologists and other groups should become familiar with the effects of synthetic cannabinoid use, and be aware of the fact that drug users may shift to these “legal” alternatives due to their nondetectability by commonly used drug screening tests based on antibodies. Sophisticated screening procedures covering the complete range of available compounds or their metabolites have to be developed for both blood/serum and urine testing.
- 1 May 2013
- Published by Springer Nature in International journal of legal medicine
- Vol. 128 (1) , 59-64
Driving under the influence of synthetic cannabinoids (“Spice”): a case series
Recreational use of synthetic cannabinoid receptor agonists—so-called “Spice” products—became very popular during the last few years. Several reports on clinical symptoms and poisonings were published. Unfortunately, most of these reports do not contain any analytical data on synthetic cannabinoids in body fluids, and no or only a limited number of cases were reported concerning driving under the influence (DUI) of this kind of drugs. In this article, several cases of DUI of synthetic cannabinoids (AM-2201, JWH-018, JWH-019, JWH-122, JWH-210, JWH-307, MAM-2201 (JWH-122 5-fluoropentyl derivative), and UR-144) are presented, focusing on analytical results and signs of impairment documented by the police or the physicians who had taken the blood sample from the suspects. Consumption of synthetic cannabinoids can lead to impairment similar to typical performance deficits caused by cannabis use which are not compatible with safe driving. These deficits include centrally sedating effects and impairment of fine motor skills necessary for keeping the vehicle on track. Police as well as forensic toxicologists and other groups should become familiar with the effects of synthetic cannabinoid use, and be aware of the fact that drug users may shift to these “legal” alternatives due to their nondetectability by commonly used drug screening tests based on antibodies. Sophisticated screening procedures covering the complete range of available compounds or their metabolites have to be developed for both blood/serum and urine testing.
- 7 April 2013
- Published by Springer Nature in Rechtsmedizin
- Vol. 23 (3) , 201-206
Positive Befunde in Haaren und Knochenmark
- 7 April 2013
- Published by Springer Nature in Rechtsmedizin
- Vol. 23 (3) , 201-206
Positive Befunde in Haaren und Knochenmark
- 16 March 2013
- Published by Springer Nature in Forensic Science, Medicine and Pathology
- Vol. 9 (2) , 218-220
Lethal neuroleptic malignant syndrome due to amisulpride
A 42-year old-man was found lying in his bed having seizures. Later he became unconscious and hypotonic developing mydriasis as well as rigidity. The body core temperature (rectal temperature) was above 42 °C. Blood pH was decreased during treatment, and his general condition deteriorated. The patient developed gasping respiration, ventricular fibrillation, and died. During autopsy and histological investigation cerebral and pulmonary edema were noted together with general congestion of the internal organs. Further observations included contraction bands of myocytes, a contracted spleen, fibrosis of the liver, and gall stones. Toxicological analyses of peripheral blood revealed the following results: amisulpride 4.65 mg/l, biperiden 0.12 mg/l, imipramine 0.33 mg/l, and desipramine 0.68 mg/l. An amisulpride-induced neuroleptic malignant syndrome was therefore diagnosed as the patho-physiological mechanism leading to death.
- 16 March 2013
- Published by Springer Nature in Forensic Science, Medicine and Pathology
- Vol. 9 (2) , 218-220
Lethal neuroleptic malignant syndrome due to amisulpride
A 42-year old-man was found lying in his bed having seizures. Later he became unconscious and hypotonic developing mydriasis as well as rigidity. The body core temperature (rectal temperature) was above 42 °C. Blood pH was decreased during treatment, and his general condition deteriorated. The patient developed gasping respiration, ventricular fibrillation, and died. During autopsy and histological investigation cerebral and pulmonary edema were noted together with general congestion of the internal organs. Further observations included contraction bands of myocytes, a contracted spleen, fibrosis of the liver, and gall stones. Toxicological analyses of peripheral blood revealed the following results: amisulpride 4.65 mg/l, biperiden 0.12 mg/l, imipramine 0.33 mg/l, and desipramine 0.68 mg/l. An amisulpride-induced neuroleptic malignant syndrome was therefore diagnosed as the patho-physiological mechanism leading to death.
- 19 February 2013
- Published by Elsevier in Forensic Science International
- Vol. 226 (1-3) , 230-234
Illegal drugs and delinquency
- 19 February 2013
- Published by Elsevier in Forensic Science International
- Vol. 226 (1-3) , 230-234
Illegal drugs and delinquency
- 6 February 2013
- Published by Wiley in Drug Testing and Analysis
- Vol. 5 (5) , 366-371
Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum and urine on an Olympus AU 400
A preliminary initial cloned enzyme donor immunoassay (CEDIA) was optimized for serum and urine drug testing with respect to the German per se limits for driving under the influence of drugs (serum) and lowered cut‐offs in cases of driving licence re‐granting (urine). The tests were performed on an Olympus AU 400 auto analyzer. Validation revealed sensitivities between 93% and 100% based on comparison with data from gas or liquid chromatography coupled with mass spectrometry. Even if specificity ranged between 83% and 98 %, the tests can be considered useful for forensic purposes. Receiver operating characteristic (ROC) curves, Youden indices, as well as positive and negative predictive values are presented. Copyright © 2013 John Wiley & Sons, Ltd.
- 6 February 2013
- Published by Wiley in Drug Testing and Analysis
- Vol. 5 (5) , 366-371
Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum and urine on an Olympus AU 400
A preliminary initial cloned enzyme donor immunoassay (CEDIA) was optimized for serum and urine drug testing with respect to the German per se limits for driving under the influence of drugs (serum) and lowered cut‐offs in cases of driving licence re‐granting (urine). The tests were performed on an Olympus AU 400 auto analyzer. Validation revealed sensitivities between 93% and 100% based on comparison with data from gas or liquid chromatography coupled with mass spectrometry. Even if specificity ranged between 83% and 98 %, the tests can be considered useful for forensic purposes. Receiver operating characteristic (ROC) curves, Youden indices, as well as positive and negative predictive values are presented. Copyright © 2013 John Wiley & Sons, Ltd.
- 6 February 2013
- Published by Wiley in Drug Testing and Analysis
- Vol. 5 (5) , 361-365
Determination of cocaine, cocaine metabolites and cannabinoids in single hairs by MALDI Fourier transform mass spectrometry – preliminary results
In a preliminary test, four single hairs of a drug abuser were analyzed for the presence of drugs by MALDI Fourier transform mass spectrometry (MALDI‐FTMS). Washed hair strains were directly fixed on a sample plate using pressure stable, double‐sided adhesive tape; α‐cyano‐4‐hydroxycinnamic acid matrix was manually spotted onto the hair strains. FTMS full scans were obtained moving from the hair root region towards the hair tip. Cocaine (accurate m/z ratio 304.15433) was identified mostly from the root of the hair and then later again towards the hair tip. This was confirmed by analysis of a second hair. Additionally cocaine metabolites with m/z ratio 290.13868 (benzoylecgonine), and m/z 318.16998 (cocaethylene) were detected for plausibility control. Using the MALDI technique, time‐related information was obtained concerning the behavioural pattern of the consumer with high resolution compared to conventional procedures. However, in two hairs of the same individual which were analyzed under the same conditions, negative results were achieved. These preliminary results confirm the applicability of MALDI‐MS for the determination of drugs and pharmaceuticals in hair samples being useful in forensic toxicology. The high chronological resolution allows an enhanced interpretation concerning the periods of drug administration. However, the negative results with two negative hairs have also demonstrated that hair analysis of single hairs can lead to misinterpretation. Different growth rates have to be considered, and particularly the phenomenon of different growth phases (anagen, catagen, telogen) require attention. Copyright © 2013 John Wiley & Sons, Ltd.
- 6 February 2013
- Published by Wiley in Drug Testing and Analysis
- Vol. 5 (5) , 361-365
Determination of cocaine, cocaine metabolites and cannabinoids in single hairs by MALDI Fourier transform mass spectrometry – preliminary results
In a preliminary test, four single hairs of a drug abuser were analyzed for the presence of drugs by MALDI Fourier transform mass spectrometry (MALDI‐FTMS). Washed hair strains were directly fixed on a sample plate using pressure stable, double‐sided adhesive tape; α‐cyano‐4‐hydroxycinnamic acid matrix was manually spotted onto the hair strains. FTMS full scans were obtained moving from the hair root region towards the hair tip. Cocaine (accurate m/z ratio 304.15433) was identified mostly from the root of the hair and then later again towards the hair tip. This was confirmed by analysis of a second hair. Additionally cocaine metabolites with m/z ratio 290.13868 (benzoylecgonine), and m/z 318.16998 (cocaethylene) were detected for plausibility control. Using the MALDI technique, time‐related information was obtained concerning the behavioural pattern of the consumer with high resolution compared to conventional procedures. However, in two hairs of the same individual which were analyzed under the same conditions, negative results were achieved. These preliminary results confirm the applicability of MALDI‐MS for the determination of drugs and pharmaceuticals in hair samples being useful in forensic toxicology. The high chronological resolution allows an enhanced interpretation concerning the periods of drug administration. However, the negative results with two negative hairs have also demonstrated that hair analysis of single hairs can lead to misinterpretation. Different growth rates have to be considered, and particularly the phenomenon of different growth phases (anagen, catagen, telogen) require attention. Copyright © 2013 John Wiley & Sons, Ltd.
- Open Access
- 27 January 2013
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 37 (3) , 186
Another Suicide Using the Veterinary Drug T61 and Distribution of Drugs in the Body
The authors recently reported about the complex suicide of a former veterinarian who injected xylazine and levomethadone together with T61, which is normally used for the euthanasia of domestic and laboratory animals (1). Furthermore, various analgesics were detected in biological samples, probably taken as painkillers for an existing cancer disease.
- 27 January 2013
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 37 (3) , 186
Open AccessAnother Suicide Using the Veterinary Drug T61 and Distribution of Drugs in the Body
The authors recently reported about the complex suicide of a former veterinarian who injected xylazine and levomethadone together with T61, which is normally used for the euthanasia of domestic and laboratory animals (1). Furthermore, various analgesics were detected in biological samples, probably taken as painkillers for an existing cancer disease.